The DOI matches its Crossref record; the references it cites are not checked yet.
Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock
Open accessAbstract
Introduction Systemic hyperfibrinolysis (accelerated clot degradation) and fibrinolysis shutdown (impaired clot degradation) are associated with increased mortality compared with physiologic fibrinolysis after trauma. Animal models have not reproduced these changes. We hypothesize rodents have a shutdown phenotype that require an exogenous profibrinolytic to differentiate mechanisms that promote or inhibit fibrinolysis.Methods Fibrinolysis resistance was assessed by thrombelastography (TEG) using exogenous tissue plasminogen activator (tPA) titrations in whole blood. There were 3 experimental groups: (1) tissue injury (laparotomy/bowel crush), (2) shock (hemorrhage to mean arterial pressure of 20 mmHg), and (3) control (arterial cannulation and tracheostomy). Baseline and 30-minute postintervention blood samples were collected, and assayed with TEG challenged with taurocholic acid (TUCA).Results Rats were resistant to exogenous tPA; the percent clot remaining 30 minutes after maximum amplitude (CL30) at 150 ng/mL (P = .511) and 300 ng/mL (P = .931) was similar to baseline, whereas 600 ng/mL (P = .046) provoked fibrinolysis. Using the TUCA challenge, the percent change in CL30 from baseline was increased in tissue injury compared with control (P = .048.), whereas CL30 decreased in shock versus control (P = .048). tPA increased in the shock group compared with tissue injury (P = .009) and control (P = .012).Conclusion Rats have an innate fibrinolysis shutdown phenotype. The TEG TUCA challenge is capable of differentiating changes in clot stability with rats undergoing different procedures. Tissue injury inhibits fibrinolysis, whereas shock promotes tPA-mediated fibrinolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fibrinolysis shutdown (resistance to tissue plasminogen activator) is a significant risk factor for hypercoagulability.
“Additionally, recent work suggests that fibrinolysis shutdown (resistance to tissue plasminogen activator—tPA) is a significant risk factor for hypercoagulability [29].”
From Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery. (2022) · cites this paper as [29]
The Results and Discussion (pages unavailable) show that rats resist tPA-mediated fibrinolysis, and the Conclusion identifies an innate fibrinolysis-shutdown phenotype. The paper does not establish that shutdown is a significant risk factor for hypercoagulability; its reported associations concern clot stability and post-trauma mortality. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists haven’t been fetched yet
References 26 · Cited by 73
Metadata
- Authors
- Moore, H. B., Moore, E. E., Lawson, P. J., Gonzalez, E., Fragoso, M., Morton, A. P., Gamboni, F., Chapman, M. P., Sauaia, A., Banerjee, A., & Silliman, C. C.
- Affiliations
- Denver Health Medical Center (US)
- University of Colorado Denver (US)
- Corresponding author
- Moore, Hunter B.
- ORCID
- Venue
- Surgery
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 158
- Issue
- 2
- Pages
- 386-392
- ISSN
- 0039-6060 (ISSN-L)
- PMC
- PMC4492895
- OpenAlex
- W1572037713
- Cited by
- 73
- References
- 26
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 10 · 2021: 6 · 2020: 12 · 2019: 8 · 2018: 5 · 2017: 8 · 2016: 6 · 2015: 4
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Surgery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (UM-1HL120877, T32-GM008315, P50-GM049222 1)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Health Sciences › Medicine › Hematology › Hemostasis and retained surgical items
- Keywords
- hyperfibrinolysis, tissue plasminogen activator, hemorrhagic shock, tissue damage, clot stability, thromboelastography, trauma-induced coagulopathy, rats
- MeSH terms
- Abdominal Injuries, Animals, Disease Models, Animal, Fibrinolysis, Fibrinolytic Agents, Male, Phenotype, Tissue Plasminogen Activator, Random Allocation, Shock, Hemorrhagic, Taurocholic Acid, Thrombelastography, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review